NCT05650476 2025-06-12Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)PfizerAvailable
NCT05491928 2022-09-01Treatment of Metastatic Cancer in Terminally Diagnosed PatientsMatrix Biomed, Inc.Available